Suchergebnisse - "Woolaver, Rachel A"

PubPharm (17)

1

Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders

enthalten in: Frontiers in immunology | 2023

von John, J. | Chen, S. | Woolaver, R. | +5

2

Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers

enthalten in: Journal of experimental & clinical cancer research : CR | 2022

von Chen, S. | Popolizio, V. | Woolaver, R. | +13

3

Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers

enthalten in: Journal of experimental & clinical cancer research | 2022

von Chen, S. | Popolizio, V. | Woolaver, R. | +13

4

Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors

enthalten in: Frontiers in immunology | 2022

von John, J. | Woolaver, R. | Popolizio, V. | +7

5

Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma

enthalten in: Communications biology | 2021

von Strait, A. | Woolaver, R. | Hall, S. | +7

6

MHC class I-independent activation of virtual memory CD8 T cells induced by chemotherapeutic agent-treated cancer cells

enthalten in: Cellular & molecular immunology | 2021

von Wang, X. | Waschke, B. | Woolaver, R. | +3

CommentIn: Cell Mol Immunol. 2021 May;18(5):1339-1340. - PMID 32620786

7

Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts

enthalten in: Journal for immunotherapy of cancer | 2021

von Woolaver, R. | Wang, X. | Krinsky, A. | +9

8

Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma

enthalten in: International journal of molecular sciences | 2020

von Chen, S. | Li, B. | Nicklawsky, A. | +9

9

TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2020

von Chen, Z. | Krinsky, A. | Woolaver, R. | +5

10

HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma

enthalten in: Protein & cell | 2020

von Wang, X. | Waschke, B. | Woolaver, R. | +3